Literature DB >> 26994152

Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon.

David R Holmes1, David P Taggart2.   

Abstract

It is now half a century since the start of coronary bypass graft surgery (CABG) with the first percutaneous coronary intervention (PCI) following just over a decade later. The relative merits of PCI vs. CABG for stable coronary artery disease (stable-CAD) have continued to be debated ever since and have been the focus of around 20 randomized trials and numerous registry studies, systematic reviews, and meta-analyses. The aim of this review is to identify areas of agreement, disagreement, and uncertainties in the role of PCI and CABG in patients with stable-CAD. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  CABG; Mammary artery; PCI; Stent; Surgery

Mesh:

Year:  2016        PMID: 26994152     DOI: 10.1093/eurheartj/ehw044

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

1.  A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation.

Authors:  Rui Wang; Jian Lu; Jiasheng Yin; Han Chen; Hongmei Liu; Fei Xu; Tongtong Zang; Rende Xu; Chenguang Li; Yizhe Wu; Qilin Wu; Xiang Fei; Meifang Zhu; Li Shen; Junbo Ge
Journal:  Bioact Mater       Date:  2022-05-11

2.  Short- and Long-Term Prognosis of Intravascular Ultrasound-Versus Angiography-Guided Percutaneous Coronary Intervention: A Meta-Analysis Involving 24,783 Patients.

Authors:  Qun Zhang; Bailu Wang; Yu Han; Shukun Sun; Ruijuan Lv; Shujian Wei
Journal:  J Interv Cardiol       Date:  2021-10-15       Impact factor: 2.279

3.  Profiles of Hospitalized Patients with Angiographic Coronary Heart Disease in Taiwan during 2014-2016: Report of a Tertiary Hospital.

Authors:  Wen-Yu Lin; Yuan Hung; Gen-Min Lin; Chin-Sheng Lin; Jun-Ting Liou; Cheng-Chung Cheng; Tsung-Neng Tsai; Wei-Che Tsai; Tzu-Chiao Lin; Wen-Cheng Liu; Pang-Yen Liu; Keng-Yi Wu; Chih-Hsueng Hsu; Fang-Han Yu; Shu-Meng Cheng; Shih-Ping Yang; Wei-Shiang Lin; Chun-Hsien Wu
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.